Cargando...

Istaroxime: A rising star in acute heart failure

Heart failure in India is a growing epidemic. Around 30 to 40% of patients die from heart failure within one year of receiving the diagnosis. Currently available inotropes have not only failed to show consistent results but are also associated with adverse outcomes. Istaroxime is a novel intravenous...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Aditya, Suruchi, Rattan, Aditya
Formato: Artigo
Idioma:Inglês
Publicado: Medknow Publications & Media Pvt Ltd 2012
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3543564/
https://ncbi.nlm.nih.gov/pubmed/23326115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-500X.103705
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!